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CONTEXT: Berardinelli-Seip congenital lipodystrophy (BSCL) is a rare recessive
disease characterized by near absence of adipose tissue, resulting in severe
dyslipidemia and insulin resistance. In most reported cases, BSCL is due to
alterations in either seipin, of unknown function, or 1-acylglycerol-3-phosphate
acyltransferase-beta (AGPAT2), which catalyzes the formation of phosphatidic
acid.
OBJECTIVE: We sought to determine the genetic origin of the unexplained cases
of BSCL. We thus sequenced CAV1, encoding caveolin-1, as a candidate gene
involved in insulin signaling and lipid homeostasis. CAV1 is a key structural
component of plasma membrane caveolae, and Cav1-deficient mice display
progressive loss of adipose tissue and insulin resistance.
DESIGN: We undertook phenotyping studies and molecular screening of CAV1 in
four patients with BSCL with no mutation in the genes encoding either seipin or
AGPAT2.
RESULTS: A homozygous nonsense mutation (p.Glu38X) was identified in CAV1 in
a patient with BSCL born from a consanguineous union. This mutation affects both
the alpha- and beta-CAV1 isoforms and ablates CAV1 expression in skin
fibroblasts. Detailed magnetic resonance imaging of the proband confirmed near
total absence of both sc and visceral adipose tissue, with only vestigial amounts in
the dorsal sc regions. In keeping with the lack of adipose tissue, the proband was
also severely insulin resistant and dyslipidemic. In addition, the proband had mild
hypocalcemia likely due to vitamin D resistance.
CONCLUSIONS: These findings identify CAV1 as a new BSCL-related gene and
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